9 research outputs found
What an Agile Leader Does: The Group Dynamics Perspective
When large industrial organizations change to (or start with) an agile approach to operations, managers and some employees are supposed to be âagile leadersâ often without being given a clear definition of what that comprises when building agile teams. An inductive thematic analysis was used to investigate what 15 appointed leaders actually do and perceive as challenges regarding group dynamics working with an agile approach. Team maturity, Team design, and Culture and mindset were all categories of challenges related to group dynamics that the practitioners face and manage in their work-life that are not explicitly mentioned in the more process-focused agile transformation frameworks. The results suggest that leader mitigation of these three aspects of group dynamics is essential to the success of an agile transformation
Resistance to phytophthora erythroseptica and pythium ultimum in a potato clone derived from s. berthaultii and s. etuberosum
Replication stress and cancer
Genome instability is a hallmark of cancer, and DNA replication is the most vulnerable cellular process that can lead to it. Any condition leading to high levels of DNA damage will result in replication stress, which is a source of genome instability and a feature of pre-cancerous and cancerous cells. Therefore, understanding the molecular basis of replication stress is crucial to the understanding of tumorigenesis. Although a negative aspect of replication stress is its prominent role in tumorigenesis, a positive aspect is that it provides a potential target for cancer therapy. In this Review, we discuss the link between persistent replication stress and tumorigenesis, with the goal of shedding light on the mechanisms underlying the initiation of an oncogenic process, which should open up new possibilities for cancer diagnostics and treatment.Research in A.A.'s laboratory is funded by grants from the Spanish Ministry of Economy and Competitiveness, the Junta de AndalucĂa, the European Union (FEDER), Worldwide Cancer Research and PharmaMar.Peer Reviewe